局部应用氨甲环酸减少初次腰椎手术失血的疗效与安全性:回顾性病例对照研究
回顾性病例对照研究纳入100例后路腰椎融合手术成人,比较局部应用氨甲环酸(tTXA)与生理盐水对照的术后失血等指标。tTXA组术后失血量、引流管拔除时间、术后住院时间均显著低于对照组,输血无显著差异,无tTXA相关并发症。
要点
- tTXA组术后失血量155.2±104.3 mL,显著低于对照组278.6±124.1 mL(P<0.05)。
- tTXA组引流管拔除时间2.0±0.6 d、术后住院时间4.7±1.4 d,均显著短于对照组。
- 两组输血无显著差异,凝血功能无显著变化,未观察到tTXA相关并发症。
核心结论
- 局部应用氨甲环酸可显著减少后路腰椎融合手术患者的术后失血量、加快引流管拔除、缩短住院时间,且不增加并发症发生率。
研究设计与样本
- 回顾性非随机病例对照研究,纳入100例接受后路腰椎融合手术的成人。
- tTXA组(n=50)在关创前用氨甲环酸(1 g溶于100 mL生理盐水)浸泡创面5分钟。
- 对照组(n=50)用等量生理盐水浸泡创面。
主要发现
- tTXA组术后失血量155.2±104.3 mL vs 对照组278.6±124.1 mL(P<0.05)。
- tTXA组引流管拔除时间2.0±0.6 d vs 对照组2.4±0.5 d(P<0.05)。
- tTXA组术后住院时间4.7±1.4 d vs 对照组5.6±2.3 d(P<0.05)。
- 两组输血无显著差异。
- 凝血功能无显著变化,未观察到氨甲环酸相关并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: A retrospective case-control study. OBJECTIVE: To compare postoperative blood loss, amount of allogeneic blood transfusion, removal time of drainage tube, length of hospital stay, and complications associated with tranexamic acid (TXA). SUMMARY OF BACKGROUND DATA: Spinal fusion surgery can be associated with significant blood loss. To the best of our knowledge, very few published studies exist reporting the effect of topical use of tranexamic acid (tTXA) on decreasing the blood loss in patients undergoing posterior lumbar spinal fusions. METHODS: We conducted a retrospective nonrandomized case-control study of 100 adults undergoing posterior lumbar spinal fusion surgery. In the tTXA group (n = 50), wound surface was soaked with TXA (1 g in 100 mL saline solution) for 5 minutes before wound closure. In the control group (n = 50), wound surface was soaked with the same volume of normal saline. The postoperative blood loss, removal time of drainage tube, amount of allogeneic blood transfusion, and length of hospital stay were compared between the two groups. And the complications of TXA were also collected. RESULTS: In the tTXA group, the postoperative blood loss, removal time of drainage tube, postoperative length of hospital stay were significantly lower than those in the control group (155.2 ± 104.3 mL vs. 278.6 ± 124.1 mL, 2.0 ± 0.6 d vs. 2.4 ± 0.5 d, 4.7 ± 1.4 d vs. 5.6 ± 2.3 d, P < 0.05, respectively). There was no significant difference in blood transfusion between two groups. No significant changes were noticed in terms of coagulation function, and no complications associated with TXA were observed. CONCLUSION: tTXA can significantly reduce postoperative blood loss, accelerate removal of drainage tube, shorten the duration of hospital stay, while not increasing the complication incidence in patients undergoing posterior lumbar spinal fusion surgery. LEVEL OF EVIDENCE: 3.
引用
- Ren Z, Li S, Sheng L, et al. Efficacy and Safety of Topical Use of Tranexamic Acid in Reducing Blood Loss During Primary Lumbar Spinal Surgery: A Retrospective Case Control Study. Spine (Phila Pa 1976). 2017. PMID: 28542107. doi:10.1097/BRS.0000000000002231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。